Risk Analysis Index Versus Modified Frailty Index: Outcomes After Otolaryngologic Surgery

风险分析指数与改良衰弱指数:耳鼻喉科手术后的结局

阅读:2

Abstract

OBJECTIVE: Patient frailty negatively impacts postsurgical outcomes across multiple specialties. Commonly used frailty scoring systems include the Modified 5-Item Frailty Index (MFI-5) and the Clinical Risk Analysis Index (RAI-C). We compared these frailty indices in predicting postsurgical outcomes in otolaryngology, a comparison that has never been completed to date. METHODS: Retrospective chart review of patients undergoing otolaryngologic surgery at a quaternary care medical center (2022-2024) with an RAI-C score available for analysis. Chi-square analysis and ROC curves were utilized to determine associations and predictive ability of each scoring system. RESULTS: Among 1209 patients, 21% met MFI-5 frailty criteria (MFI-5 score > 1), and 23% met RAI-C frailty criteria (RAI-C score > 30). The Pearson correlation coefficient between MFI-5 and RAI-C was 0.481 (95% CI [0.43, 0.53]), indicating a moderate correlation between the two metrics. Patients deemed frail by RAI-C had 5.7 times higher odds of experiencing a postoperative complication than non-frail counterparts (95% CI [3.51, 9.28], p < 0.0001), but MFI-5 frailty status was not associated with postoperative complications. Both RAI-C and MFI-5 demonstrated significant predictive ability for 30-day readmission (AUC 0.77, 95% CI [0.64, 0.89] vs. AUC 0.76, 95% CI [0.61, 0.88]), respectively. When compared to MFI-5, RAI-C had greater predictive performance for all other postoperative outcomes in this study. CONCLUSION: RAI-C outperformed MFI-5 in predicting postoperative outcomes in patients undergoing otolaryngologic surgeries. RAI-C assessment should be considered in frailty research, multidisciplinary treatment planning, and managing patient expectations and outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。